Hajare Kashmira Rajendra, Patil Priya, Bansode Jyoti
Department of Medicine, GGMC and JJ Group of Hospitals, Mumbai, Maharashtra, India.
Indian J Crit Care Med. 2018 May;22(5):369-371. doi: 10.4103/ijccm.IJCCM_464_17.
Idiopathic systemic capillary leak syndrome (ISCLS) is a very rare life-threatening disorder characterized by recurrent episodes of hypotension, hemoconcentration, and hypoalbuminemia. It is caused by transient endothelial dysfunction, leading to plasma leakage from intravascular to interstitial space. Here, we report a case of ISCLS with recurrent episodes of capillary leak which required a long-term prophylaxis with beta-2 adrenergic receptor agonist and theophylline. Although ISCLS is the rare entity, associated morbidity and mortality require physician's awareness to provide timely therapy. Under-recognition in the medical community and rarity of this syndrome has precluded analysis in rational clinical trial designs that are necessary to determine targeted and adequate therapy. This report is meant to enhance awareness of ISCLS among physician's community.
特发性系统性毛细血管渗漏综合征(ISCLS)是一种非常罕见的危及生命的疾病,其特征为反复发作的低血压、血液浓缩和低白蛋白血症。它由短暂的内皮功能障碍引起,导致血浆从血管内渗漏到间质间隙。在此,我们报告一例ISCLS患者,该患者反复出现毛细血管渗漏,需要长期使用β-2肾上腺素能受体激动剂和茶碱进行预防。尽管ISCLS是一种罕见疾病,但相关的发病率和死亡率要求医生提高认识以便及时进行治疗。医学界对该综合征认识不足以及其罕见性使得在确定靶向和充分治疗所必需的合理临床试验设计中无法进行分析。本报告旨在提高医生群体对ISCLS的认识。